| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Revenue | $1.69B | +9.8% |
| Cost of Revenue | $1.09B | +8.8% |
| Gross Profit | $596.5M | +11.5% |
| R&D Expense | $7.5M | +102.7% |
| SG&A Expense | $439.8M | +3.6% |
| Operating Income | $156.6M | +41.8% |
| Pre-tax Income | $147.1M | +54.3% |
| Income Tax | $40.1M | +63.4% |
| Net Income | $107.1M |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $389.4M | +0.9% |
| Accounts Receivable | $418.6M | +13.3% |
| Inventory | $36.0M | -9.3% |
| Current Assets | $950.5M | +10.8% |
| Total Assets | $1.64B | +4.2% |
| Current Liabilities | $302.1M | -1.4% |
| Long-term Debt | $411.4M | +37.5% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $206.9M | +54.2% |
| Capital Expenditures | $9.7M | +173.3% |
| Investing Cash Flow | -$110.8M | +33.1% |
| Financing Cash Flow | -$93.3M | -145.6% |
| Free Cash Flow | $197.1M | +51.0% |
| +49.9% |
| EPS (Basic) | $2.58 | +44.9% |
| EPS (Diluted) | $2.52 | +47.4% |
| Total Liabilities |
| $831.0M |
| +7.5% |
| Stockholders' Equity | $812.6M | +1.0% |